Product Program year 2025 Source: CMS Open Payments

BD Veritor Plus Analyzer

Device Diagnostic Testing

PDI 00382902560661

Open in the dashboard

General payments

$918

34 payments

Research payments

$4,348,884

102 payments

Through program year 2025, $918 in general payments and $4,348,884 in research payments were reported against BD Veritor Plus Analyzer (Diagnostic Testing).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $893 33
2025 Research $1,295,727 21
2024 General $25 1
2024 Research $863,900 42
2023 Research $2,189,257 39

Breakdown

Who paid General payments · program years 2024–2025
  1. Becton, Dickinson and Company $918 34 payments
Top recipients General payments · program year 2025
  1. Christ-Ann Magloire Obstetrics & Gynecology · North Miami Beach, FL $78 9% · 2 payments
  2. Michael Wagoner Anatomic Pathology & Clinical Pathology · Tampa, FL $67 8% · 5 payments
  3. Lemuel Gorden Montgomery, AL $57 6% · 1 payment
  4. Edward Benak Anatomic Pathology & Clinical Pathology · Montgomery, AL $57 6% · 1 payment
  5. Nella Fernandez Clinical Pathology/Laboratory Medicine · Montgomery, AL $57 6% · 1 payment

The top 5 of 26 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Family Medicine $180 22% · 6 practitioners
  2. Obstetrics & Gynecology $166 20% · 5 practitioners
  3. Anatomic Pathology & Clinical Pathology Pathology $165 20% · 3 practitioners
  4. Clinical Pathology/Laboratory Medicine Pathology $57 7% · 1 practitioner
  5. Nurse Practitioner $55 7% · 2 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $569 64% · 16 recipients
  2. Alabama $172 19% · 3 recipients
  3. Massachusetts $76 8% · 4 recipients
  4. Utah $36 4% · 1 recipient
  5. New Jersey $20 2% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

34 general · 102 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record